Biktarvy is a prescription medication used to treat HIV-1 infection.
It is a combination of three antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide.
Like all medications, Biktarvy can cause side effects in some people who take it.
One potential side effect of Biktarvy is lactic acidosis, which is a build-up of lactic acid in the blood.
Some common side effects.
Lactic acidosis can cause symptoms such as stomach pain, muscle cramps, weakness, difficulty breathing, dizziness, and fatigue.
It is a rare but serious condition that can be life-threatening if left untreated.
Another side effect of Biktarvy is liver damage.
This can cause symptoms such as yellowing of the skin and whites of the eyes, dark urine, and abdominal pain.
People who have liver problems or who drink large amounts of alcohol may be more at risk for this side effect.
In addition to lactic acidosis and liver damage, Biktarvy can also cause other side effects such as nausea, diarrhea, and headache.
These side effects are typically mild and may go away on their own over time.
Despite these potential side effects, Biktarvy is generally well-tolerated and effective at treating HIV-1 infection.
It is important for people who are taking Biktarvy to report any side effects to their healthcare provider so that they can be monitored and treated if necessary.
Risks you should be concerned about.
It is important to weigh the potential risks and benefits of any medication before starting treatment.
For people living with HIV-1 infection, the benefits of taking Biktarvy may far outweigh the potential risks of side effects. HIV-1 is a chronic, incurable disease that, if left untreated, can lead to serious health complications and even death.
Biktarvy can help to suppress the virus, prevent the progression of the disease, and improve the overall quality of life for people living with HIV-1.
In conclusion, Biktarvy is an effective medication for treating HIV-1 infection, but it can cause adverse effects in some people.
It is important for people who are taking Biktarvy to report any side effects to their healthcare provider and to weigh the potential risks and benefits of treatment before starting therapy.
Despite the potential risks, the benefits of taking Biktarvy can far outweigh these risks for people living with HIV-1 infection.